Company / Gross Margin
Haemonetics Gross Margin History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
52.8%
FY2026
5-year range
52.6% / 55.0%
FY2022-FY2026
Trend
-
vs FY2025
Sector context
#58 of 96
Health Care
What the data says
At 52.8%, Haemonetics's gross margin ranks #58 of 96 in the Health Care sector.
Based on SEC 10-K filings.
52.8% in FY2026 with a 5-year CAGR of +1.9%.
Remained stable around 52.8% over the past 3 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- +0.0pp
- 5-Year Change
- +1.9pp
- 10-Year Change
- -
Sector benchmark
#58 of 96 in Health CareTop 60% of 96This company 52.8% Sector average 53.6%
▼
-1.4% below sector average
Key checks
Key Insights
- Currently 0.8pp below the Health Care sector average.
- Peak gross margin was recorded in FY2017.
- Lowest gross margin in the period was in FY2021.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | 52.8% | - |
| FY2025 | - | - |
| FY2024 | 55.0% | +4.2% |
| FY2023 | 52.8% | +0.4% |
| FY2022 | 52.6% | +3.4% |
| FY2021 | 50.9% | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | 182.8% | +327.9% |
As of FY2026 · SEC 10-K · Updated Jun 30, 2026